What is Hyster-Yale, Inc.'s earnings per share (EPS)?

Hyster-Yale, Inc. (HY) reported diluted earnings per share of -$3.40 for fiscal year 2025. This represents a -142.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Hyster-Yale, Inc. (HY) Financials

Trailing 12 months to June 30, 2026

Revenue $3.5B -11.1% YoY

Net Income -$116.9M -626.6% YoY

EPS (Diluted) -$6.57 -634.1% YoY

Free Cash Flow $14.8M -83.7% YoY

Market Cap $523.6M as of Oct 22, 2026

Price / Sales 0.1x on $3.5B revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 1.3x on $390.0M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 22, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HY SEC filings page.

Hyster-Yale, Inc. (HY) reported $3.5B in revenue over the twelve months to Jun 30, 2026, down 11.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HY FY2025 2026-10-04

The business can generate cash with moderate leverage, but FY2025 exposed how quickly weaker volume and margins erase profits.

The 2025 net loss of $60.1M coexisted with operating cash flow of $86.1M, but cash generation was not purely earnings-driven. After investment, free cash flow was $23.6M; inventory fell by $120M, indicating that working-capital release helped fund cash flow during the downturn.

Revenue fell from $4.3B in FY2024 to $3.8B in FY2025, showing a meaningful contraction in activity. Gross margin compression from 20.8% to 16.8% indicates that weaker results reflected reduced profitability per sale, not just fewer sales.

Despite the earnings reversal, FY2025 debt-to-equity remained near 0.5x and the current ratio near 1.3x, so leverage and short-term coverage did not materially deteriorate. Total liabilities of $1.5B against $472M of equity still show a balance sheet financed substantially by obligations rather than shareholder capital.

Financial Health Signals

Financial Health Score 30/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Hyster-Yale, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Hyster-Yale, Inc. has an operating margin of -0.6%, meaning the company loses $1 on every $100 of revenue. This results in a profitability score of 29/100. This is down from 5.7% the prior year.

Growth

Hyster-Yale, Inc.'s revenue declined 12.5% year-over-year, from $4.3B to $3.8B. This contraction results in a growth score of 18/100.

Leverage

Hyster-Yale, Inc. has elevated debt relative to equity (D/E of 0.53), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 10/100, reflecting increased financial risk.

Liquidity

Hyster-Yale, Inc.'s current ratio of 1.34 indicates adequate short-term liquidity, earning a score of 36/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While Hyster-Yale, Inc. generated $86.1M in operating cash flow, capex of $62.5M consumed most of it, leaving $23.6M in free cash flow. This results in a low score of 32/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Hyster-Yale, Inc. posts a -12.7% return on equity (ROE), meaning it loses $13 for every $100 of shareholders' equity. This results in a returns score of 52/100. This is down from 29.9% the prior year.

Altman Z-Score Grey Zone

2.44

Hyster-Yale, Inc. scores 2.44, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from revenue of $3.8B against total assets of $2.0B. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/8

Hyster-Yale, Inc. passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

Hyster-Yale, Inc. reported a net loss of $60.1M while generating $86.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Hyster-Yale, Inc. reported an operating loss of $22.1M against $31.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$812.9M

YoY-15.0%

QoQ+2.2%

5Y CAGR+1.2%

10Y CAGR+2.3%

Hyster-Yale, Inc. generated $812.9M in revenue in Q2 2026. This represents a decrease of 15.0% from the same quarter a year earlier. Against the prior quarter it is up 2.2%.

EBITDA

-$7.5M

YoY-327.3%

QoQn/m

Hyster-Yale, Inc.'s EBITDA was -$7.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 327.3% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income

-$31.6M

YoYn/m

QoQn/m

Hyster-Yale, Inc. reported a net loss of $31.6M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

-$1.76

YoYn/m

QoQn/m

Hyster-Yale, Inc. earned -$1.76 per diluted share (EPS) in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow

$2.0M

YoY-86.8%

QoQn/m

5Y CAGRn/m

10Y CAGRn/m

Hyster-Yale, Inc. generated $2.0M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 86.8% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt

$72.6M

YoY+8.5%

QoQ-11.2%

5Y CAGR-3.7%

10Y CAGR+3.5%

Hyster-Yale, Inc. held $72.6M in cash against $259.2M in long-term debt as of Q2 2026.

Dividends Per Share

$0.36

YoY+1.4%

QoQ+1.4%

5Y CAGR+2.5%

10Y CAGR+2.2%

Hyster-Yale, Inc. paid $0.36 per share in dividends in Q2 2026. This represents an increase of 1.4% from the same quarter a year earlier. Against the prior quarter it is up 1.4%.

Shares Outstanding

Diluted avg 18M

Hyster-Yale, Inc. had a weighted average of 18M diluted shares in Q2 2026; the shares outstanding count is not reported for that period.

Margins & Returns

Gross Margin

15.7%

YoY-1.9pp

QoQ0.0pp

5Y change+0.5pp

10Y change-2.0pp

Hyster-Yale, Inc.'s gross margin was 15.7% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 1.9 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.

Operating Margin

-2.3%

YoY-1.4pp

QoQ+1.3pp

5Y change-3.0pp

10Y change-4.0pp

Hyster-Yale, Inc.'s operating margin was -2.3% in Q2 2026, reflecting core business profitability. This is down 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.

Net Margin

-3.9%

YoY-2.4pp

QoQ-0.1pp

5Y change-4.1pp

10Y change-5.2pp

Hyster-Yale, Inc.'s net profit margin was -3.9% in Q2 2026, showing the share of revenue converted to profit. This is down 2.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Return on Equity

-8.1%

YoY-5.6pp

QoQ-1.0pp

5Y change-8.4pp

10Y change-9.8pp

Hyster-Yale, Inc.'s quarterly ROE was -8.1% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 5.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.0 percentage points.

Capital Allocation

Share Buybacks

YoY-100.0%

QoQ-100.0%

Hyster-Yale, Inc. repurchased no shares in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

Capital Expenditures

$14.7M

YoY+6.5%

QoQ+50.0%

5Y CAGR+7.2%

10Y CAGR+3.3%

Hyster-Yale, Inc. invested $14.7M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 6.5% from the same quarter a year earlier. Against the prior quarter it is up 50.0%.

R&D Spending

Not reported for Q2 2026.

HY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HY quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$3.5B	$3.8B-12.5%	$4.3B+4.6%	$4.1B+16.1%	$3.5B+15.4%	$3.1B+9.4%	$2.8B-14.6%	$3.3B+3.5%	$3.2B+10.2%	$2.9B+12.3%	$2.6B-0.3%	$2.6B-6.8%	$2.8B+3.8%	$2.7B+8.0%	$2.5B-2.8%	$2.5B
Cost of Revenue	$3.0B	$3.1B-8.1%	$3.4B+2.4%	$3.3B+7.0%	$3.1B+14.8%	$2.7B+15.6%	$2.3B-14.7%	$2.8B+2.5%	$2.7B+12.6%	$2.4B+11.2%	$2.1B-0.2%	$2.1B-7.4%	$2.3B+5.2%	$2.2B+6.7%	$2.1B-4.2%	$2.2B
Gross Profit	$539.3M	$632.8M-29.3%	$895.5M+14.0%	$785.6M+81.1%	$433.9M+19.4%	$363.4M-21.9%	$465.4M-14.1%	$541.8M+9.0%	$497.0M-1.1%	$502.6M+17.6%	$427.5M-0.8%	$430.8M-3.8%	$447.7M-2.9%	$461.0M+14.3%	$403.2M+5.1%	$383.5M
R&D Expenses	N/A	$137.2M+1.0%	$135.9M+13.5%	$119.7M+18.9%	$100.7M-7.0%	$108.3M+7.8%	$100.5M-12.8%	$115.3M+4.0%	$110.9M+6.1%	$104.5M-2.3%	$107.0M+21.2%	$88.3M+23.7%	$71.4M+3.2%	$69.2M+2.5%	$67.5M+10.1%	$61.3M
SG&A Expenses	$594.8M	$616.5M-1.8%	$628.1M+8.9%	$576.9M+22.0%	$473.0M+5.1%	$450.1M+8.3%	$415.5M-14.8%	$487.9M+6.5%	$458.2M+6.9%	$428.5M+8.6%	$394.6M+20.6%	$327.3M+3.3%	$316.7M-3.1%	$326.8M+12.1%	$291.4M+6.5%	$273.5M
Operating Income	-$81.3M	-$22.1M-109.0%	$244.8M+17.3%	$208.7Mn/m	-$39.1Mn/m	-$152.3M-405.2%	$49.9M-7.4%	$53.9M+38.9%	$38.8M-47.6%	$74.1M+125.2%	$32.9M-68.2%	$103.5M-30.4%	$148.8M+10.8%	$134.3M+20.2%	$111.7M+1.5%	$110.0M
EBITDA	N/A	$23.7M-91.9%	$292.4M+15.2%	$253.8M+5802.3%	$4.3Mn/m	-$106.1M-214.3%	$92.8M-4.5%	$97.2M+17.4%	$82.8M-29.2%	$116.9M+62.4%	$72.0M-45.6%	$132.4M-25.8%	$178.5M+8.5%	$164.5M+17.8%	$139.7M-1.1%	$141.3M
Interest Expense	$30.6M	$31.2M-7.7%	$33.8M-9.4%	$37.3M+31.3%	$28.4M+83.2%	$15.5M+13.1%	$13.7M-30.8%	$19.8M+23.8%	$16.0M+9.6%	$14.6M+117.9%	$6.7M+42.6%	$4.7M+20.5%	$3.9M-56.7%	$9.0M-27.4%	$12.4M-21.5%	$15.8M
Income Tax	$13.1M	$15.1M-79.8%	$74.8M+41.4%	$52.9M+475.0%	$9.2M-67.5%	$28.3M+664.9%	$3.7M-67.3%	$11.3M+391.3%	$2.3M-94.9%	$44.9Mn/m	-$4.0M-113.6%	$29.4M-26.3%	$39.9M+132.0%	$17.2M+145.7%	$7.0M-63.0%	$18.9M
Net Income	-$116.9M	-$60.1M-142.2%	$142.3M+13.0%	$125.9Mn/m	-$74.1Mn/m	-$173.0M-566.3%	$37.1M+3.6%	$35.8M+3.2%	$34.7M-28.6%	$48.6M+13.6%	$42.8M-42.7%	$74.7M-32.0%	$109.8M-0.2%	$110.0M+12.2%	$98.0M+18.6%	$82.6M
EPS (Basic)	N/A	-$3.40-141.7%	$8.16+11.0%	$7.35n/m	-$4.38n/m	-$10.29-565.6%	$2.21+2.8%	$2.15+2.4%	$2.10-28.8%	$2.95+13.0%	$2.61-43.0%	$4.58-30.7%	$6.61+0.5%	$6.58+12.7%	$5.84+18.5%	$4.93
EPS (Diluted)	-$6.57	-$3.40-142.3%	$8.04+11.0%	$7.24n/m	-$4.38n/m	-$10.29-565.6%	$2.21+3.3%	$2.14+2.4%	$2.09-28.9%	$2.94+12.6%	$2.61-42.9%	$4.57-30.5%	$6.58+0.6%	$6.54+12.2%	$5.83+18.7%	$4.91
Diluted Shares (Avg)	N/A	18M-0.2%	18M+1.9%	17M+2.9%	17M+0.5%	17M+0.1%	17M+0.4%	17M+0.7%	17M+0.5%	17M+0.5%	16M+0.4%	16M-1.9%	17M-0.8%	17M0.0%	17M-0.1%	17M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$812.9M-15.0%	$795.2M-12.7%	$923.2M-13.5%	$979.1M-3.6%	$956.6M-18.1%	$910.4M-13.8%	$1.1B+3.9%	$1.0B+1.5%
Cost of Revenue	$685.3M-13.1%	$670.4M-8.5%	$792.2M-7.9%	$823.2M0.0%	$788.4M-13.2%	$732.7M-10.7%	$859.9M+5.2%	$823.2M+3.2%
Gross Profit	$127.6M-24.1%	$124.8M-29.8%	$131.0M-36.9%	$155.9M-19.2%	$168.2M-35.1%	$177.7M-24.6%	$207.6M-1.0%	$192.9M-5.3%
SG&A Expenses	$144.3M-10.4%	$151.2M-3.2%	$146.7M-4.7%	$152.6M-3.8%	$161.0M-1.6%	$156.2M+2.8%	$153.9M-4.4%	$158.6M+9.4%
Operating Income	-$18.4Mn/m	-$28.0M-231.5%	-$37.2M-215.2%	$2.3M-93.1%	-$8.5M-108.9%	$21.3M-74.6%	$32.3M-33.7%	$33.1M-43.5%
EBITDA	-$7.5M-327.3%	-$16.7M-151.7%	-$25.5M-157.8%	$13.6M-69.6%	$3.3M-96.9%	$32.3M-66.2%	$44.1M-26.5%	$44.8M-35.9%
Interest Expense	$7.8M-1.3%	$7.2M-6.5%	$7.6M-1.3%	$8.0M-4.8%	$7.9M-10.2%	$7.7M-13.5%	$7.7M-15.4%	$8.4M-12.5%
Income Tax	$8.1M+3950.0%	-$1.8M-122.2%	$9.7M-27.1%	-$2.9M-128.2%	$200K-99.2%	$8.1M-67.7%	$13.3M-16.9%	$10.3M-36.4%
Net Income	-$31.6Mn/m	-$30.5M-454.7%	-$52.5M-609.7%	-$2.3M-113.4%	-$13.9M-122.0%	$8.6M-83.3%	$10.3M-59.1%	$17.2M-52.0%
EPS (Basic)	-$1.76n/m	-$1.71-449.0%	-$2.97-603.4%	-$0.13-113.3%	-$0.79-121.8%	$0.49-83.5%	$0.59-59.9%	$0.98-52.9%
EPS (Diluted)	-$1.76n/m	-$1.71-456.3%	-$2.97-621.1%	-$0.13-113.4%	-$0.79-122.1%	$0.48-83.6%	$0.57-59.9%	$0.97-52.9%
Diluted Shares (Avg)	18M+1.2%	18M+0.3%	N/A	18M-0.2%	18M+0.3%	18M+1.0%	N/A	18M+1.9%

Not reported in any period shown, so not listed: R&D Expenses.

HY Balance Sheet

HY quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$2.0B-0.4%	$2.0B-2.4%	$2.1B+2.6%	$2.0B+2.8%	$2.0B+5.9%	$1.9B+0.7%	$1.8B+6.0%	$1.7B+5.7%	$1.6B+28.0%	$1.3B+17.4%	$1.1B-2.2%	$1.1B-3.5%	$1.2B+9.1%	$1.1B-4.7%	$1.1B
Current Assets	$1.3B-6.0%	$1.4B-3.8%	$1.5B+2.2%	$1.5B+8.1%	$1.4B+19.5%	$1.1B-2.3%	$1.2B+2.1%	$1.1B0.0%	$1.1B+39.7%	$810.0M-1.1%	$818.9M-3.2%	$846.2M-8.2%	$921.6M+10.8%	$831.8M-7.4%	$898.4M
Cash & Equivalents	$123.2M+27.5%	$96.6M+22.6%	$78.8M+33.6%	$59.0M-9.9%	$65.5M-56.7%	$151.4M+134.4%	$64.6M-22.8%	$83.7M-62.0%	$220.1M+409.5%	$43.2M-72.1%	$155.1M+39.2%	$111.4M-36.6%	$175.7M+16.1%	$151.3M-18.2%	$184.9M
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Inventory	$634.3M-15.9%	$754.3M-7.5%	$815.7M+2.0%	$799.5M+2.4%	$781.0M+53.3%	$509.4M-9.0%	$559.9M+4.9%	$533.6M+29.5%	$411.9M+17.0%	$352.2M+15.6%	$304.6M-11.1%	$342.5M+3.6%	$330.6M+7.1%	$308.6M-0.1%	$309.0M
Accounts Receivable	$489.6M+0.2%	$488.4M-1.8%	$497.5M-5.0%	$523.6M+14.5%	$457.4M+11.0%	$412.1M-12.0%	$468.3M+0.6%	$465.5M+2.8%	$453.0M+20.7%	$375.3M+15.8%	$324.1M-9.4%	$357.7M-0.4%	$359.3M+9.1%	$329.2M-9.5%	$363.8M
Long-Term Investments	$0n/m	$0n/m	$0	N/A	N/A	$2.1M-12.5%	$2.4M-41.5%	$4.1M-56.4%	$9.4Mn/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Goodwill	$55.7M+2.0%	$54.6M+2.4%	$53.3M+3.9%	$51.3M-9.2%	$56.5M-50.7%	$114.7M+7.5%	$106.7M-1.5%	$108.3M+83.2%	$59.1M+16.6%	$50.7Mn/m	$0	N/A	N/A	N/A	N/A
Total Liabilities	$1.5B-0.4%	$1.5B-8.2%	$1.7B-7.2%	$1.8B+13.5%	$1.6B+31.3%	$1.2B-4.9%	$1.3B+7.4%	$1.2B+10.0%	$1.1B+31.7%	$816.7M+29.0%	$633.2M-4.8%	$664.8M-6.4%	$710.4M-1.6%	$722.2M-11.9%	$819.9M
Current Liabilities	$1.0B-5.3%	$1.1B-13.2%	$1.2B-9.3%	$1.3B+21.6%	$1.1B+46.1%	$755.9M-7.5%	$817.0M+5.3%	$776.2M+12.1%	$692.4M+20.1%	$576.5M+14.1%	$505.2M-8.6%	$552.8M-9.3%	$609.8M+20.7%	$505.2M-23.6%	$661.2M
Non-Current Liabilities	$526.4M+10.3%	$477.2M+5.2%	$453.7M-1.0%	$458.2M-5.1%	$482.6M+6.7%	$452.5M-0.2%	$453.2M+11.5%	$406.4M+6.1%	$383.1M+59.5%	$240.2M+87.7%	$128.0M+14.3%	$112.0M+11.3%	$100.6M-53.6%	$217.0M+36.7%	$158.7M
Long-Term Debt	$251.9M+4.1%	$241.9M+0.2%	$241.3M-9.6%	$267.0M+2.0%	$261.7M+27.0%	$206.1M+0.7%	$204.7M-2.6%	$210.1M-2.8%	$216.2M+163.0%	$82.2M+319.4%	$19.6M+63.3%	$12.0M+79.1%	$6.7M-93.7%	$106.9M+95.8%	$54.6M
Total Equity	$472.0M-0.7%	$475.1M+21.9%	$389.9M+90.8%	$204.4M-42.8%	$357.1M-42.1%	$616.9M+13.3%	$544.3M+3.2%	$527.4M-6.7%	$565.5M+21.9%	$463.8M+0.7%	$460.8M+1.4%	$454.5M+1.0%	$449.8M+31.8%	$341.3M+15.2%	$296.3M
Retained Earnings	$289.1M-22.8%	$374.6M+46.2%	$256.3M+67.8%	$152.7M-38.6%	$248.6M-43.9%	$443.2M+3.7%	$427.4M+4.9%	$407.3M+4.7%	$389.1M+8.0%	$360.3M+7.0%	$336.7M+20.1%	$280.4M+48.8%	$188.4M+98.1%	$95.1Mn/m	-$2.9M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$1.9B-7.1%	$2.0B-4.7%	$2.0B-0.4%	$2.1B-5.2%	$2.1B-1.9%	$2.1B-3.0%	$2.0B-2.4%	$2.2B+5.8%
Current Assets	$1.3B-12.3%	$1.3B-10.3%	$1.3B-6.0%	$1.4B-7.4%	$1.5B-4.7%	$1.5B-4.7%	$1.4B-3.8%	$1.6B+3.9%
Cash & Equivalents	$72.6M+8.5%	$81.8M+6.0%	$123.2M+27.5%	$71.1M-6.0%	$66.9M+0.6%	$77.2M+24.1%	$96.6M+22.6%	$75.6M-3.3%
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Inventory	$627.5M-19.2%	$643.8M-16.7%	$634.3M-15.9%	$740.3M-13.4%	$776.6M-1.8%	$772.7M-8.2%	$754.3M-7.5%	$855.3M+4.9%
Accounts Receivable	$484.8M-5.3%	$471.2M-6.9%	$489.6M+0.2%	$520.6M-4.0%	$512.1M-11.5%	$506.1M-2.8%	$488.4M-1.8%	$542.5M+6.0%
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Goodwill	$55.5M+0.2%	$54.6M+6.6%	$55.7M+2.0%	$55.5M-4.6%	$55.4M+7.4%	$51.2M-1.5%	$54.6M+2.4%	$58.2M+14.1%
Total Liabilities	$1.5B+0.4%	$1.5B-1.2%	$1.5B-0.4%	$1.5B-7.3%	$1.5B-7.5%	$1.5B-9.7%	$1.5B-8.2%	$1.6B-6.3%
Current Liabilities	$999.6M-4.1%	$992.9M-5.8%	$1.0B-5.3%	$1.0B-9.7%	$1.0B-11.0%	$1.1B-13.7%	$1.1B-13.2%	$1.1B-11.6%
Non-Current Liabilities	$518.6M+10.5%	$514.3M+9.0%	$526.4M+10.3%	$468.1M-1.4%	$469.5M+1.6%	$472.0M+0.8%	$477.2M+5.2%	$474.7M+9.6%
Long-Term Debt	$259.2M+5.7%	$251.1M+3.5%	$251.9M+4.1%	$252.2M+1.9%	$245.2M-1.3%	$242.6M+1.2%	$241.9M+0.2%	$247.4M+1.7%
Total Equity	$390.0M-28.4%	$430.1M-15.7%	$472.0M-0.7%	$536.0M+1.2%	$544.7M+17.0%	$510.0M+23.8%	$475.1M+21.9%	$529.9M+74.1%
Retained Earnings	$214.0M-40.0%	$252.2M-33.1%	$289.1M-22.8%	$348.1M-6.0%	$356.7M-0.7%	$377.0M+24.8%	$374.6M+46.2%	$370.4M+56.5%

HY Cash Flow Statement

HY quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$77.4M	$86.1M-49.6%	$170.7M+13.3%	$150.7M+271.2%	$40.6Mn/m	-$253.5M-251.9%	$166.9M+117.6%	$76.7M+13.5%	$67.6M-59.0%	$164.7Mn/m	-$48.9M-154.7%	$89.4M-10.6%	$100.0M-34.6%	$152.9M+18.8%	$128.7M+135.7%	$54.6M
Depreciation & Amortization	N/A	$45.8M-3.8%	$47.6M+5.5%	$45.1M+3.9%	$43.4M-6.1%	$46.2M+7.7%	$42.9M-0.9%	$43.3M-1.6%	$44.0M+2.8%	$42.8M+9.5%	$39.1M+35.3%	$28.9M-2.7%	$29.7M-1.7%	$30.2M+7.9%	$28.0M-10.5%	$31.3M
Stock-Based Compensation	N/A	$7.5M-68.2%	$23.6M-19.5%	$29.3M+357.8%	$6.4M+60.0%	$4.0M+207.7%	$1.3M-84.1%	$8.2M+43.9%	$5.7M-35.2%	$8.8M+79.6%	$4.9M+69.0%	$2.9M-51.7%	$6.0M-57.7%	$14.2M+992.3%	$1.3Mn/m	$0
Capital Expenditures	$62.6M	$62.5M+30.8%	$47.8M+35.0%	$35.4M+22.9%	$28.8M-35.0%	$44.3M-14.3%	$51.7M+4.0%	$49.7M+28.1%	$38.8M-5.4%	$41.0M-4.0%	$42.7M-8.4%	$46.6M-3.9%	$48.5M+32.9%	$36.5M+84.3%	$19.8M+20.0%	$16.5M
Free Cash Flow	$14.8M	$23.6M-80.8%	$122.9M+6.6%	$115.3M+877.1%	$11.8Mn/m	-$297.8M-358.5%	$115.2M+326.7%	$27.0M-6.3%	$28.8M-76.7%	$123.7Mn/m	-$91.6M-314.0%	$42.8M-16.9%	$51.5M-55.8%	$116.4M+6.9%	$108.9M+185.8%	$38.1M
Investing Cash Flow	-$60.6M	-$62.7Mn/m	-$47.6Mn/m	-$34.5Mn/m	-$35.4Mn/m	-$24.5Mn/m	-$43.7Mn/m	-$42.0Mn/m	-$110.9Mn/m	-$47.3Mn/m	-$145.1Mn/m	-$31.3M	N/A	N/A	-$19.5Mn/m	-$15.9M
Financing Cash Flow	-$10.5M	-$800Kn/m	-$100.1Mn/m	-$100.5Mn/m	-$10.9M-105.6%	$193.6Mn/m	-$40.6Mn/m	-$51.6Mn/m	-$87.6M-265.0%	$53.1M-31.8%	$77.9Mn/m	-$7.1M	N/A	N/A	-$144.4Mn/m	-$19.5M
Dividends Paid	$25.8M	$25.4M+5.8%	$24.0M+7.6%	$22.3M+2.3%	$21.8M+0.9%	$21.6M+1.4%	$21.3M+1.4%	$21.0M+2.9%	$20.4M+3.0%	$19.8M+3.1%	$19.2M+4.3%	$18.4M+3.4%	$17.8M+6.6%	$16.7M-55.8%	$37.8Mn/m	$0
Share Buybacks	-$8.2M	-$4.5M-67.9%	-$14.0Mn/m	$0n/m	$0	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$100K-99.8%	$48.2M+1506.7%	$3.0M+36.4%	$2.2Mn/m	$0

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$16.7M-42.2%	-$32.9Mn/m	$56.5M-30.0%	$37.1M-47.1%	$28.9Mn/m	-$36.4M-262.5%	$80.7M+77.0%	$70.1M+16.3%
Depreciation & Amortization	$10.9M-7.6%	$11.3M+2.7%	$11.7M-0.8%	$11.3M-3.4%	$11.8M-4.8%	$11.0M-6.0%	$11.8M+4.4%	$11.7M+3.5%
Stock-Based Compensation	N/A	$4.4M+25.7%	N/A	N/A	N/A	$3.5M-62.0%	N/A	N/A
Capital Expenditures	$14.7M+6.5%	$9.8M-7.5%	$23.6M+31.8%	$14.5M+42.2%	$13.8M+13.1%	$10.6M+41.3%	$17.9M+8.5%	$10.2M+22.9%
Free Cash Flow	$2.0M-86.8%	-$42.7Mn/m	$32.9M-47.6%	$22.6M-62.3%	$15.1Mn/m	-$47.0M-415.4%	$62.8M+115.8%	$59.9M+15.2%
Investing Cash Flow	-$14.2Mn/m	-$9.3Mn/m	-$22.9Mn/m	-$14.2Mn/m	-$15.3Mn/m	-$10.3Mn/m	-$16.9Mn/m	-$12.0Mn/m
Financing Cash Flow	-$11.3Mn/m	$1.3M-95.0%	$17.6Mn/m	-$18.1Mn/m	-$26.2M-237.2%	$25.9Mn/m	-$37.9Mn/m	-$50.8Mn/m
Dividends Paid	$6.6M+3.1%	$6.4M+3.2%	$6.5M+6.6%	$6.3M+3.3%	$6.4M+4.9%	$6.2M+8.8%	$6.1M+8.9%	$6.1M+8.9%
Share Buybacks	$0-100.0%	$700K-84.4%	-$9.0M-61.0%	$100Kn/m	-$100Kn/m	$4.5M-50.5%	-$23.1M+23000.0%	$0n/m

HY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HY quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	16.8%-4.0pp	20.8%+1.7pp	19.1%+6.8pp	12.2%+0.4pp	11.8%-4.7pp	16.6%+0.1pp	16.5%+0.8pp	15.6%-1.8pp	17.4%+0.8pp	16.6%-0.1pp	16.7%+0.5pp	16.2%-1.1pp	17.3%+1.0pp	16.3%+1.2pp	15.1%
Operating Margin	-0.6%-6.3pp	5.7%+0.6pp	5.1%+6.2pp	-1.1%+3.9pp	-5.0%-6.7pp	1.8%+0.1pp	1.6%+0.4pp	1.2%-1.4pp	2.6%+1.3pp	1.3%-2.7pp	4.0%-1.4pp	5.4%+0.3pp	5.0%+0.5pp	4.5%+0.2pp	4.3%
Net Margin	-1.6%-4.9pp	3.3%+0.2pp	3.1%+5.1pp	-2.1%+3.5pp	-5.6%-6.9pp	1.3%+0.2pp	1.1%0.0pp	1.1%-0.6pp	1.7%0.0pp	1.7%-1.2pp	2.9%-1.1pp	4.0%-0.2pp	4.1%+0.2pp	4.0%+0.7pp	3.3%
Return on Equity	-12.7%-42.7pp	29.9%-2.3pp	32.3%+68.5pp	-36.3%+12.2pp	-48.4%-54.5pp	6.0%-0.6pp	6.6%0.0pp	6.6%-2.0pp	8.6%-0.6pp	9.2%-7.0pp	16.2%-8.0pp	24.2%-0.3pp	24.5%-4.3pp	28.7%+0.8pp	27.9%
Return on Assets	-3.0%-10.0pp	7.0%+0.9pp	6.1%+9.7pp	-3.7%+5.1pp	-8.8%-10.8pp	2.0%+0.1pp	1.9%-0.1pp	2.0%-1.0pp	2.9%-0.4pp	3.3%-3.5pp	6.8%-3.0pp	9.8%+0.3pp	9.5%+0.3pp	9.2%+1.8pp	7.4%
Current Ratio	1.340.0x	1.35+0.1x	1.22+0.1x	1.09-0.1x	1.22-0.3x	1.49+0.1x	1.410.0x	1.46-0.2x	1.63+0.2x	1.41-0.2x	1.62+0.1x	1.530.0x	1.51-0.1x	1.65+0.3x	1.36
Debt-to-Equity	0.530.0x	0.51-0.1x	0.62-0.7x	1.31+0.6x	0.73+0.4x	0.330.0x	0.380.0x	0.400.0x	0.38+0.2x	0.18+0.1x	0.040.0x	0.030.0x	0.01-0.3x	0.31+0.1x	0.18
Liabilities-to-Equity	3.240.0x	3.23-1.1x	4.29-4.5x	8.81+4.4x	4.44+2.5x	1.96-0.4x	2.33+0.1x	2.24+0.3x	1.90+0.1x	1.76+0.4x	1.37-0.1x	1.46-0.1x	1.58-0.5x	2.12-0.7x	2.77
Asset Turnover	1.87-0.3x	2.12+0.1x	1.98+0.2x	1.75+0.2x	1.560.0x	1.51-0.3x	1.780.0x	1.82+0.1x	1.75-0.2x	2.00-0.4x	2.35-0.1x	2.47+0.2x	2.300.0x	2.320.0x	2.27
FCF Margin	0.6%-2.2pp	2.9%+0.1pp	2.8%+2.5pp	0.3%+10.0pp	-9.7%-13.8pp	4.1%+3.3pp	0.8%-0.1pp	0.9%-3.4pp	4.3%+7.8pp	-3.6%-5.2pp	1.7%-0.2pp	1.9%-2.5pp	4.4%0.0pp	4.4%+2.9pp	1.5%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	15.7%-1.9pp	15.7%-3.8pp	14.2%-5.3pp	15.9%-3.1pp	17.6%-4.6pp	19.5%-2.8pp	19.4%-1.0pp	19.0%-1.4pp
Operating Margin	-2.3%-1.4pp	-3.5%-5.9pp	-4.0%-7.1pp	0.2%-3.0pp	-0.9%-9.1pp	2.3%-5.6pp	3.0%-1.7pp	3.3%-2.6pp
Net Margin	-3.9%-2.4pp	-3.8%-4.8pp	-5.7%-6.7pp	-0.2%-1.9pp	-1.5%-6.9pp	0.9%-3.9pp	1.0%-1.5pp	1.7%-1.9pp
Return on Equity	-8.1%-5.6pp	-7.1%-8.8pp	-11.1%-13.3pp	-0.4%-3.7pp	-2.5%-16.1pp	1.7%-10.8pp	2.2%-4.3pp	3.3%-8.5pp
Return on Assets	-1.6%-1.0pp	-1.6%-2.0pp	-2.6%-3.1pp	-0.1%-0.9pp	-0.7%-3.7pp	0.4%-2.0pp	0.5%-0.7pp	0.8%-0.9pp
Current Ratio	1.28-0.1x	1.31-0.1x	1.340.0x	1.390.0x	1.40+0.1x	1.38+0.1x	1.35+0.1x	1.36+0.2x
Debt-to-Equity	0.66+0.2x	0.58+0.1x	0.530.0x	0.470.0x	0.45-0.1x	0.48-0.1x	0.51-0.1x	0.47-0.3x
Liabilities-to-Equity	3.89+1.1x	3.50+0.5x	3.240.0x	2.81-0.3x	2.78-0.7x	2.99-1.1x	3.23-1.1x	3.06-2.6x
Asset Turnover	0.420.0x	0.410.0x	0.46-0.1x	0.480.0x	0.46-0.1x	0.44-0.1x	0.530.0x	0.470.0x
FCF Margin	0.3%-1.3pp	-5.4%-0.2pp	3.6%-2.3pp	2.3%-3.6pp	1.6%+2.8pp	-5.2%-6.6pp	5.9%+3.0pp	5.9%+0.7pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Hyster-Yale, Inc. HY	FY2025	$3.8B	-$60.1M	-1.6%	$523.6M	30/100
Titan International, Inc.(Delaware) TWI	FY2025	$1.8B	-$63.5M	-3.5%	$441.5M	39/100
Wabash National Corp. WNC	FY2025	$1.5B	$211.5M	13.7%	$528.0M	37/100
Columbus McKinnon Corp/NY CMCO	FY2026	$1.2B	-$229.5M	-19.2%	$421.7M	38/100
The Manitowoc Company, Inc. MTW	FY2025	$2.2B	$7.2M	0.3%	$820.4M	35/100
Astec Industries Inc ASTE	FY2025	$1.4B	$38.8M	2.8%	$909.6M	43/100

Where Hyster-Yale, Inc. Ranks

Frequently Asked Questions

What is Hyster-Yale, Inc.'s annual revenue?

Hyster-Yale, Inc. (HY) reported $3.8B in total revenue for fiscal year 2025. This represents a -12.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Hyster-Yale, Inc.'s revenue growing?

Hyster-Yale, Inc. (HY) revenue declined by 12.5% year-over-year, from $4.3B to $3.8B in fiscal year 2025.

Is Hyster-Yale, Inc. profitable?

No, Hyster-Yale, Inc. (HY) reported a net loss of $116.9M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $60.1M, with a net profit margin of -1.6%.

What is Hyster-Yale, Inc.'s EBITDA?

Hyster-Yale, Inc. (HY) had EBITDA of $23.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Hyster-Yale, Inc. have?

As of fiscal year 2025, Hyster-Yale, Inc. (HY) had $123.2M in cash and equivalents against $251.9M in long-term debt.

What is Hyster-Yale, Inc.'s gross margin?

Hyster-Yale, Inc. (HY) had a gross margin of 16.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Hyster-Yale, Inc.'s operating margin?

Hyster-Yale, Inc. (HY) had an operating margin of -0.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Hyster-Yale, Inc.'s net profit margin?

Hyster-Yale, Inc. (HY) had a net profit margin of -1.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Hyster-Yale, Inc. pay dividends?

Yes, Hyster-Yale, Inc. (HY) paid $1.43 per share in dividends during fiscal year 2025.

What is Hyster-Yale, Inc.'s return on equity (ROE)?

Hyster-Yale, Inc. (HY) has a return on equity of -12.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Hyster-Yale, Inc.'s free cash flow?

Hyster-Yale, Inc. (HY) generated $23.6M in free cash flow during fiscal year 2025. This represents a -80.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Hyster-Yale, Inc.'s operating cash flow?

Hyster-Yale, Inc. (HY) generated $86.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Hyster-Yale, Inc.'s total assets?

Hyster-Yale, Inc. (HY) had $2.0B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Hyster-Yale, Inc.'s capital expenditures?

Hyster-Yale, Inc. (HY) invested $62.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Hyster-Yale, Inc. spend on research and development?

Hyster-Yale, Inc. (HY) invested $137.2M in research and development during fiscal year 2025.

Does Hyster-Yale, Inc. buy back shares?

Yes, Hyster-Yale, Inc. (HY) spent $4.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

What is Hyster-Yale, Inc.'s current ratio?

Hyster-Yale, Inc. (HY) had a current ratio of 1.34 as of fiscal year 2025, which is considered adequate.

What is Hyster-Yale, Inc.'s debt-to-equity ratio?

Hyster-Yale, Inc. (HY) had a debt-to-equity ratio of 0.53 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is Hyster-Yale, Inc.'s liabilities-to-equity ratio?

Hyster-Yale, Inc. (HY) had a liabilities-to-equity ratio of 3.24 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is Hyster-Yale, Inc.'s return on assets (ROA)?

Hyster-Yale, Inc. (HY) had a return on assets of -3.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Hyster-Yale, Inc.'s P/E ratio?

Hyster-Yale, Inc. (HY) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $523.6M as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Hyster-Yale, Inc.'s price-to-sales ratio?

Hyster-Yale, Inc. (HY) trades at 0.1x sales, its market capitalization divided by $3.5B revenue, trailing 12 months to June 30, 2026. The market capitalization is $523.6M as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Hyster-Yale, Inc.'s Altman Z-Score?

Hyster-Yale, Inc. (HY) has an Altman Z-Score of 2.44, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Hyster-Yale, Inc.'s Piotroski F-Score?

Hyster-Yale, Inc. (HY) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Hyster-Yale, Inc.'s earnings high quality?

Hyster-Yale, Inc. (HY) reported a net loss of $60.1M while generating $86.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Hyster-Yale, Inc. cover its interest payments?

Hyster-Yale, Inc. (HY) reported an operating loss of $22.1M against $31.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Hyster-Yale, Inc.?

Hyster-Yale, Inc. (HY) scores 30 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.